Patents by Inventor Philip Marsden

Philip Marsden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Metal complexes
    Patent number: 10717754
    Abstract: Metal complexes such as those of formula (I) are contemplated by the present invention. The metal complexes may be used in catalytic reactions as a catalyst. The catalytic reaction may be an autotransfer process, for example hydrogen borrowing. Improved catalytic activity has been observed with certain metal complexes of the invention.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: July 21, 2020
    Assignee: University of Leeds
    Inventors: Stephen Philip Marsden, Patrick Columba McGowan, Roberta Lanaro, Andrew John Blacker
  • METAL COMPLEXES
    Publication number: 20180362566
    Abstract: Metal complexes such as those of formula (I) are contemplated by the present invention. The metal complexes may be used in catalytic reactions as a catalyst. The catalytic reaction may be an autotransfer process, for example hydrogen borrowing.
    Type: Application
    Filed: December 19, 2016
    Publication date: December 20, 2018
    Inventors: Stephen Philip MARSDEN, Patrick Columba MCGOWAN, Roberta LANARO, Andrew John BLACKER
  • NOVEL LINCRNA AND INTERFERING NUCLEIC ACID MOLECULES, COMPOSITIONS AND METHODS AND USES THEREOF FOR REGULATING ANGIOGENESIS AND RELATED CONDITIONS
    Publication number: 20160220599
    Abstract: The present disclosure provides a large intergenic RNA (LIVE) and compositions thereof. Also provided is a nucleic acid molecule that silences the expression of the LIVE. Further provided are methods and uses of the compositions for modulating angiogenesis.
    Type: Application
    Filed: September 26, 2014
    Publication date: August 4, 2016
    Inventors: Philip A. Marsden, Sunit Das, Jenny Jing Wang, Megan Yijun Wu
  • MODULATION OF CD200 RECEPTORS
    Publication number: 20080267967
    Abstract: The present invention relates to CD200 receptor isoforms and modulators thereof and their use in methods of immune modulation and pharmaceutical compositions.
    Type: Application
    Filed: March 27, 2008
    Publication date: October 30, 2008
    Inventors: Reginald M. GORCZYNSKI, Philip MARSDEN
  • CD200 receptors
    Patent number: 7368535
    Abstract: The present invention relates to CD200 receptor isoforms and modulators thereof and their use in methods of immune modulation and pharmaceutical compositions.
    Type: Grant
    Filed: May 24, 2002
    Date of Patent: May 6, 2008
    Assignee: Trillium Therapeutics Inc.
    Inventors: Reginald M. Gorczynski, Philip Marsden
  • Modulation of cd200 receptors
    Publication number: 20050107314
    Abstract: The present invention relates to CD200 receptor isoforms and modulators thereof and their use in methods of immune modulation and pharmaceutical compositions.
    Type: Application
    Filed: May 24, 2002
    Publication date: May 19, 2005
    Inventors: Reginald Gorczynski, Philip Marsden
  • Treatment of chronic human viral hepatitis
    Publication number: 20050042226
    Abstract: The use of Fgl2 inhibitors to treat and control the progression of human Hepatitis B virus-induced hepatitis is described. Inhibitors of Fgl2 include antibodies to Fgl2.
    Type: Application
    Filed: June 25, 2004
    Publication date: February 24, 2005
    Applicant: Trillium Therapeutics Inc.
    Inventors: Gary Levy, Philip Marsden
  • Fgl-2 knockout mice
    Patent number: 6642433
    Abstract: A knockout mouse in which the Fgl-2 gene has been suppressed is described. The mouse is useful in studying the role of Fgl-2 in normal and disease states including viral hepatitis, allograph rejection, fetal loss, inflammatory bowel disease, lupus glomerulonephritis; acute respiratory disease syndrome, Whipple's disease, cancer and for developing therapies to treat these diseases.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: November 4, 2003
    Assignee: Trillium Therapeutics Inc.
    Inventors: Gary Levy, Philip Marsden, Laisum Fung